Pulling the latest in this topic…
C-suite moves, stocks, investments, M&A
2682 briefings briefings in Business
The latest AI listing race turns fundraising speed into a competitive weapon, with regulators and boards watching closely.
The orbital infrastructure thesis is the real IPO story, and it could force regulators and markets to rethink what space funding is for.
GSK’s new CEO commits to a major oncology bet: the $10.6bn Nuvalent deal deepens its late-stage pipeline for lung cancer.
The industry says aircraft can be evacuated in 90 seconds, but hand-luggage grabs and videos can turn that into disaster.
Her viral story ties “attitude” complaints to practical hiring friction and why it changes how managers screen.
A Bitcoin drop could erase the “Saylor Magic Premium” and trigger dilution and preferred payouts Strategy may not cover.
BYD bets China’s EV race keeps expanding, even as some expect domestic demand to cool further.
What one HK$110 million retail sale signals about how McDonald's is re-monetizing long-held property across Hong Kong.
The Paramount chief legal officer accuses Netflix of trying to derail the Warner Bros. Discovery deal at regulators, after Teamsters raised job fears.
The filing backs fast monetization, while bigger losses and a still-murky valuation question force sharper scrutiny.
A one-day Manhattan event, tied to the same-day Capitol Records release, gives fans a week-long window while stock lasts.
OpenAI’s leaders say AI must stay safe and under human control as agentic automation becomes the enterprise battleground.
